Evidence map›Paper›PMID 12815097›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.

Erik I Christensen, Olivier Devuyst, Geneviève Dom, Rikke Nielsen, Patrick Van der Smissen, Pierre Verroust, Michèle Leruth, William B Guggino, Pierre J Courtoy

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it, 317 citations in OpenAlex.

  1. Dent disease: clinical practice recommendations.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Guideline
  2. Trial
  3. Article
  4. Article
  5. Megalin: from structure to function.Nature reviews. Nephrology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Transferrin receptors.Experimental & molecular medicine · 2025
    Review
  15. Protein handling in kidney tubules.Nature reviews. Nephrology · 2025
    Review
  16. TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV.Journal of the American Society of Nephrology : JASN · 2025
    Article
  17. Review
  18. To treat or not to treat: CUBN-associated persistent proteinuria.Kidney research and clinical practice · 2024
    Article
  19. Article
  20. Emerging roles of proximal tubular endocytosis in renal fibrosis.Frontiers in cell and developmental biology · 2023
    Review

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Erik I ChristensenInstitute of Anatomy, Department of Cell Biology, University of Aarhus, DK-8000 Aarhus C, Denmark.
Olivier Devuyst
Geneviève Dom
Rikke Nielsen
Patrick Van der Smissen
Pierre Verroust
Michèle Leruth
William B Guggino
Pierre J Courtoy
de Duve Institute · BE

Funding

STORAGE AND INTERCELLULAR TRANSFER OF VITAMIN A IN LIVERR01DK032793 · NIDDK · IOWA STATE UNIVERSITY · PI OLSON, JAMES A · 1986 to 1988
–
NIDDK NIH HHS DK32793
6 · The paper itself

Abstract

Loss of the renal endosome-associated chloride channel, ClC-5, in Dent's disease and knockout (KO) mice strongly inhibits endocytosis of filtered proteins by kidney proximal tubular cells (PTC). The underlying mechanism remains unknown. We therefore tested whether this endocytic failure could primarily reflect a loss of reabsorption by the multiligand receptors, megalin, and cubilin, caused by a trafficking defect. Impaired protein endocytosis in PTC of ClC-5 KO mice was demonstrated by (i) a major decreased uptake of injected 125I-beta 2-microglobulin, but not of the fluid-phase tracer, FITC-dextran, (ii) reduced labeling of endosomes by injected peroxidase and for the endogenous megalin/cubilin ligands, vitamin D- and retinol-binding proteins, and (iii) urinary appearance of low-molecular-weight proteins and the selective cubilin ligand, transferrin. Contrasting with preserved mRNA levels, megalin and cubilin abundance was significantly decreased in kidney extracts of KO mice. Percoll gradients resolving early and late endosomes (Rab5a, Rab7), brush border (villin, aminopeptidase M), and a dense peak comprising lysosomes (acid hydrolases) showed a disappearance of the brush border component for megalin and cubilin in KO mice. Quantitative ultrastructural immunogold labeling confirmed the overall decrease of megalin and cubilin in PTC and their selective loss at the brush border. In contrast, total contents of the rate-limiting endocytic catalysts, Rab5a and Rab7, were unaffected. Thus, impaired protein endocytosis caused by invalidation of ClC-5 primarily reflects a trafficking defect of megalin and cubilin in PTC.

Indexed as

EndocytosisProtein TransportAbsorptionAnimalsBlood ProteinsCell PolarityChloride ChannelsEndosomesFanconi SyndromeHydrogen-Ion ConcentrationImmunohistochemistryIon TransportKidney Tubules, ProximalLigandsLow Density Lipoprotein Receptor-Related Protein-2MaleBlood ProteinsChloride ChannelsCLC5 protein, mouseintrinsic factor-cobalamin receptorLigandsLow Density Lipoprotein Receptor-Related Protein-2rab5 GTP-Binding Proteinsrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, mouserab GTP-Binding ProteinsReceptors, Cell SurfaceRNA, Messenger

Identifiers

PMID12815097
PMCPMC166253
OpenAlexW2104521051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.